XT
RNTX

XTX Topco’s Rein Therapeutics RNTX Stock Holding History

XTX Topco’s Portfolio RNTX Stock Details RNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$42.8K Buy
+32,924
New +$40.8K ﹤0.01% 3358
2025
Q4 		– Sell
-14,984
Closed -$17.2K – 3948
2025
Q3 		$17.2K Buy
+14,984
New +$19K ﹤0.01% 2357
2025
Q1 		– Sell
-16,038
Closed -$36.9K – 3265
2024
Q4 		$36.9K Buy
+16,038
New +$48.6K ﹤0.01% 1944

Other funds holding RNTX

VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TCBWMS
Texas Capital Bank Wealth Management Services Dallas, Texas $1.68B AUM 21.72% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

XTX Topco's RNTX Position: Q1 2026 in Review

XTX Topco opened a new position in Rein Therapeutics (RNTX) in Q1 2026: 32,924 shares worth $42.8K. The stake represents ﹤0.01% of the portfolio and ranks #3358 among its holdings. This is a return to the name: XTX Topco previously reported a position in RNTX as recently as Q3 2025.

XTX Topco first reported a position in RNTX in Q4 2024 and has held it in 3 quarters since. 46 funds tracked by Wall St. Rank hold RNTX as of Q1 2026.

  • XTX Topco held 32,924 shares of Rein Therapeutics worth $42.8K as of Q1 2026.
  • Rein Therapeutics was a new XTX Topco position in Q1 2026.
  • Rein Therapeutics made up ﹤0.01% of XTX Topco's portfolio in Q1 2026, its #3358 holding.
  • XTX Topco first reported a position in Rein Therapeutics in Q4 2024 and has held it in 3 quarters since.
  • 46 funds tracked by Wall St. Rank held Rein Therapeutics as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.